Is biote Corp (BTMD) overvalued? · P/E 5.3, rev $197.2M
biote Corp (BTMD) is a medical care facilities company listed on NASDAQ.
This page asks whether biote Corp (BTMD) looks expensive on cached numbers — not a short thesis.
Latest reported BTMD revenue for 2024-12-31 was $197.2M. Net income was $46.0K. Revenue was up 6.4% from 2023-12-31 to 2024-12-31. BTMD currently screens at market cap $80.7M and trailing P/E 5.3.
BTMD currently screens at market cap $80.7M and trailing P/E 5.3. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next BTMD 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the BTMD stock page for the full model, not this heading.
Not investment advice.